FSGS

Clinical trials for FSGS explained in plain language.

Never miss a new study

Get alerted when new FSGS trials appear

Sign up with your email to follow new studies for FSGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Completed 1

New hope for FSGS: experimental drug APL2 enters Late-Stage trial

Disease control Not yet recruiting

This study tests a drug called APL2 for people with a kidney disease called FSGS, which causes protein leakage in urine and can lead to kidney failure. The trial has two parts: first, adults receive APL2 to see if it works; then, adults and teens are randomly assigned to get APL2…

Matched conditions: FSGS

Phase: PHASE2, PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 07, 2026 18:42 UTC

FSGS

Get alerted when new FSGS trials appear

New hope for FSGS: experimental drug APL2 enters Late-Stage trial